Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WXSH0176 in active ulcerative colitis (Phase IIa, randomized, double-blind, placebo-controlled)
CTR20243189Phase 2Completed
- Sponsor
- Cisen Pharmaceutical Co., Ltd.
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of WXSH0176 in autoimmune colitis, sponsored by Cisen Pharmaceutical Co., Ltd.. Started Sep 2024; status: completed.
02
Drugs
WXSH0176
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on CTR20243189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243189.